Analysts Could Be Undervaluing This Healthcare Giant's Potential
August 14, 2015 at 09:26 AM EDT
In a report published Friday, Piper Jaffray analyst Richard J. Purkiss maintained an Overweight rating on Pfizer Inc. (NYSE: PFE), with ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
